The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...
The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21.
Revive Therapeutics (RVTTF), RedHill BioPharma...
News and Charts on Four Small Cap Telehealth and Remote Health Monitoring Plays.
After Losing $33 Billion in Value, Teladoc Health Snags an Upgrade.
With chances building...
Reuniting With the Affable Mr. Greg Halpern, 19 Years Later…
A Potential Christmas Present Arrives in our lap Early, From the Inventor of Crowdfunding and Winner of Incubator of The Year in...
VYRE Streaming Network Partners with UNIFD.
With Clients Like McDonald's, Budweiser, CBS Sports, Norton and Intuit-TurboTax, "UNIFD is the Largest Independent Audio & Connected TV Marketplace, Period."
VYRE Network (CAPV) Now Integrated With Samsung TV
Las Vegas, Nevada--(Newsfile Corp. - December 10, 2021) - VYRE Network (OTC Pink: CAPV) (a wholly-owned Cabo Verde Capital company, "VYRE") is pleased to announce that...
Adding VYRE Network (CAPV) to the Watch List.
Look What We Found. Our First Internet Play in Ages, And It's a Doozy.
We would categorize this...
He Shoots and He Scores. Dicerna (DRNA) up 78%.
Our Second $3.00 Watch List Company Gets Acquired for Over $1 Billion. As They say "You Can't Make This **** Up."
The Alkaline Water Company (WTER) Reports Record Second Quarter Revenue with 50% Year over...
$15.25 Million in Revenue is Best Quarter in Company History
SCOTTSDALE, Ariz., November 09, 2021–(BUSINESS WIRE)–The Alkaline Water Company...
Adding Beach Body (BODY) $3.90 to the Watch List.
This is Like Shooting Fish in the Barrell, but the Fish Shoot Back.
We’re not traders, but we...
And We Have Our First MEME Stock! $2.00 to $29.95.
Tiny U.S. Biotech Jumps 930% as It Picks Up Retail Attention (Bloomberg)
Guess we were bound to stumble across...
Latest article
Our Best Risk to Reward Idea Ever?
Adding Revive Therapeutics (RVVTF, RVV.CN) to the "2022, Biotech 12 pack, 12 Biotech Stocks We Expect to...
ImmixBio (IMMX) Announces Positive Clinical Trial Safety Data.
Demonstrates 100% Completion of Planned Treatment Cycles.
Immix Biopharma, Inc. Wed, January 19, 2022.
ImmixBio...
Everything You Need to Know About FDA’s Priority Review Vouchers Worth $100’s of Millions.
Never Heard of These 'PRV's' but What a Potential Bonanza for the Recipients. They're transferable - as in they can be...
